Omnicef Plus 200mg/200mg Tablet is a combination antibiotic formulation containing Cefixime 200mg and Ofloxacin 200mg, indicated for the treatment of a wide range of bacterial infections. Cefixime, a third-generation cephalosporin, exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, thereby disrupting cell integrity and leading to cell death. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and transcription, resulting in the inhibition of bacterial growth. This synergistic combination enhances the antimicrobial spectrum, making Omnicef Plus effective against various Gram-positive and Gram-negative pathogens responsible for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted infections. The tablet is administered orally, with dosing tailored according to the severity and type of infection, as well as patient-specific factors such as renal function. Caution is advised in patients with hypersensitivity to cephalosporins or fluoroquinolones, and potential side effects include gastrointestinal disturbances, hypersensitivity reactions, and central nervous system effects. Omnicef Plus should be used under medical supervision to ensure appropriate use and to minimize the risk of antibiotic resistance.